Preferred
(EDT)

GIPR Antagonist Antibodies Conjugated to GLP-1 Peptides Decrease Weight in Obese Preclinical Models

6:40 PM - 7:05 PM EST
Monday, February 1, 2021Room: V200 Jeremy
Other
Central Adaptations to Body Weight Change

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.